 |
HYDERABAD, India, June 30, 2026 /PRNewswire/ — Shantha Biologics today announced that it has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India.
The agreement with Novo Nordisk reflects Shantha Biologics’ continued focus on high-quality manufacturing execution and its role as a trusted partner to global healthcare companies. The collaboration will be governed by the parties’ agreed contractual framework and carried out in accordance with applicable quality, compliance, and regulatory requirements.
“We are pleased to enter into this collaboration, which reflects the confidence placed in Shantha Biologics’ capabilities and our commitment to reliable, high-quality cartridge fill-finish services,” said Dr. Vishy Chebrol, Director, Shantha Biologics. “We look forward to supporting this partnership through strong operational execution and a continued focus on quality and compliance.”
No financial terms or further details of the agreement are being disclosed.
About Shantha Biologics
Shantha Biologics is a pharmaceutical manufacturing company based in Hyderabad, India, with capabilities spanning vaccines, biologics, and specialized sterile manufacturing. The company operates purpose-built sterile fill-finish capacity, including cartridge filling, and partners with global pharmaceutical and biotechnology companies to deliver high-quality development and aseptic manufacturing that meets international quality and compliance standards.
Media Contact:
|
Dr MRK Raju +91 996 358 1033 |
Sashi Pochimcharla +91 994 905 4060 |
ข่าวที่เกี่ยวข้อง
- DXC แต่งตั้ง Lisa Beaudoin ดำรงตำแหน่งประธานเจ้าหน้าที่ฝ่ายผลิตภัณฑ์ เพื่อเร่งขับเคลื่อนการเติบโตด้วยกลยุทธ์ที่มีผลิตภัณฑ์เป็นศูนย์กลาง
- LingEQ Study Finds: The Most Cognitively Dense Paper in 90 Years of AI History Was Not Written About AI
- MONDEVITA เข้าซื้อหุ้นส่วนใหญ่ใน UNDERSCORE DISTRICT บริษัทผู้ดูแลธุรกิจแบรนด์ MAGLIANO เดินหน้าสู่ก้าวที่สองของการสร้างแพลตฟอร์มธุรกิจลักชัวรีสัญชาติอิตาลีแห่งใหม่
- ชุมชนธุรกิจจีน-สหรัฐฯ กระชับความสัมพันธ์ สำรวจโอกาสใหม่ด้านความร่วมมือห่วงโซ่อุปทาน
